Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 2026, 'Factors affecting hospital inpatient blood pressure measurement as ranked by a Delphi survey', Scientific Reports, 16, http://dx.doi.org/10.1038/s41598-026-46429-6
, 2026, 'Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial', Nephrology Dialysis Transplantation, pp. gfag203, http://dx.doi.org/10.1093/ndt/gfag203
, 2026, 'Efficacy and Safety of Atrasentan in Patients with IgA Nephropathy Receiving Sodium-Glucose Cotransporter 2 Inhibitors: Placebo-Controlled, Crossover Trial', Journal of the American Society of Nephrology, 37, pp. 2004 - 2015, http://dx.doi.org/10.1681/ASN.0000001076
, 2026, 'Efficacy and Safety of Simultaneous Initiation of SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease or Heart Failure', Jacc Heart Failure, 14, http://dx.doi.org/10.1016/j.jchf.2026.103106
, 2026, 'Burden of chronic kidney disease and outcomes following hospitalisation for heart failure', Heart British Cardiac Society, 112, pp. 1033 - 1040, http://dx.doi.org/10.1136/heartjnl-2025-327053
, 2026, 'A Dose of Perspective: A Multinational Survey of Patient and Clinician Views on Combination Therapy in CKD', Kidney360, 7, pp. 1772 - 1780, http://dx.doi.org/10.34067/KID.0000001227
, 2026, 'Sodium-glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes and Chronic Kidney Disease Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20 mL/min/1.73 m2', Journal of Cardiac Failure, 32, pp. 1408 - 1417, http://dx.doi.org/10.1016/j.cardfail.2026.01.020
, 2026, 'Prevalence of CKD Among Adults in Africa: A Systematic Review and Meta-Analysis', American Journal of Kidney Diseases, 88, pp. 44 - 66.e1, http://dx.doi.org/10.1053/j.ajkd.2026.02.640
, 2026, 'Comparing Catheters to Fistulas in Older Patients Starting Hemodialysis (ACCESS HD)', Journal of the American Society of Nephrology, Publish Ahead of Print, http://dx.doi.org/10.1681/ASN.0000001160
, 2026, 'Sex disparities in receiving evidence-based medications in patients with CKD', Nephrology Dialysis Transplantation, pp. gfag135, http://dx.doi.org/10.1093/ndt/gfag135
, 2026, 'Advances in understanding the impact of sex on kidney health and disease', Lancet, 407, pp. 2429 - 2443, http://dx.doi.org/10.1016/S0140-6736(26)00654-9
, 2026, 'Eye on AKI - Are shifting trends the cue for a platform clinical trial?', Journal of Critical Care, 93, http://dx.doi.org/10.1016/j.jcrc.2026.155438
, 2026, 'How Accurate Is Inpatient Blood Pressure Measurement?', Hypertension, 83, pp. e26355, http://dx.doi.org/10.1161/HYPERTENSIONAHA.125.26355
, 2026, 'Building CRESCENDO – a global registry of glomerulonephritis with crescents', Clinical Kidney Journal, http://dx.doi.org/10.1093/ckj/sfag077
, 2026, 'Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset', Diabetes Obesity and Metabolism, 28, pp. 2329 - 2338, http://dx.doi.org/10.1111/dom.70428
, 2026, 'Availability and readiness of health facilities for chronic kidney disease, diabetes and cardiovascular disease in Ethiopia: Evidence from service provision assessment data', Diabetes Obesity and Metabolism, 28, pp. 960 - 971, http://dx.doi.org/10.1111/dom.70268
, 2026, 'Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice Dataset', Kidney360, 7, pp. 312 - 320, http://dx.doi.org/10.34067/KID.0000000988
, 2026, 'A scoping review of specialist hypertension clinics', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.70533
, 2026, 'Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level Pooled Analysis from the CANVAS Program and CREDENCE Trial', Journal of Cardiac Failure, 32, pp. 151 - 156, http://dx.doi.org/10.1016/j.cardfail.2025.05.021
, 2026, 'Haemodialysis catheter utilisation and factors associated with catheter-related bloodstream infection in Aotearoa New Zealand: Report from the binational, prospective, cluster-randomised trial', Internal Medicine Journal, 56, pp. 72 - 82, http://dx.doi.org/10.1111/imj.70279
, 2026, 'International Society of Nephrology International Expert Forum: Exploring the Nexus of Cardiovascular-Kidney-Metabolic Health', Kidney International, http://dx.doi.org/10.1016/j.kint.2026.06.044
, 2026, 'Mass Spectrometric Measurements of 11-Deoxycortisol, Androstenedione and Dehydroepiandrosterone Are Superior to Cortisol to Assess Selectivity of Non-Stimulated Adrenal Vein Sampling', Clinical Endocrinology, 104, pp. 10 - 18, http://dx.doi.org/10.1111/cen.70037
, 2026, 'WCN26-2797 Impact of Polypharmacy on the Efficacy and Safety of SGLT2 Inhibitors in Patients with Chronic Kidney Disease: Insights from the CREDENCE trial', Kidney International Reports, 11, pp. 104597, http://dx.doi.org/10.1016/j.ekir.2026.104597
, 2026, 'WCN26-2801 EXPLORING CULTURAL SAFETY AND EQUITY IN CHRONIC KIDNEY DISEASE CARE ACROSS AFRICA: PROTOCOL FOR A MULTI-COUNTRY QUALITATIVE INQUIRY', Kidney International Reports, 11, pp. 105998 - 105998, http://dx.doi.org/10.1016/j.ekir.2026.105998
, 2026, 'WCN26-2964 AVAILABILITY AND READINESS OF HEALTH FACILITIES FOR CHRONIC KIDNEY DISEASE, DIABETES, AND CARDIOVASCULAR DISEASE IN ETHIOPIA: EVIDENCE FROM SERVICE PROVISION ASSESSMENT DATA', Kidney International Reports, 11, pp. 104723 - 104723, http://dx.doi.org/10.1016/j.ekir.2026.104723
, 2026, 'WCN26-5467 ASPIrin to Reduce Events in Dialysis (ASPIRED) trial: a pragmatic, registry-based, double-blind randomized clinical trial', Kidney International Reports, 11, pp. 104237 - 104237, http://dx.doi.org/10.1016/j.ekir.2026.104237
, 2026, 'WCN26-6333 SOCIO-GEOGRAPHIC DIFFERENCES IN CKD MORTALITY IN AUSTRALIA', Kidney International Reports, 11, pp. 104851 - 104851, http://dx.doi.org/10.1016/j.ekir.2026.104851
, 2026, 'WCN26-7232 EFFECTS OF CANAGLIFLOZIN ON BETA-CELL FUNCTION AND INSULIN RESISTANCE IN TYPE 2 DIABETES MELLITUS: DATA FROM THE CANVAS TRIAL', Kidney International Reports, 11, pp. 104640, http://dx.doi.org/10.1016/j.ekir.2026.104640
, 2025, 'The Association between Low-Grade Proteinuria and Adverse Kidney Outcomes in IgA Nephropathy: A Systematic Review and Meta-Analysis', Clinical Journal of the American Society of Nephrology, http://dx.doi.org/10.2215/CJN.0000000952
, 2025, 'Canagliflozin in patients with type 2 Diabetes and CKD experiencing deterioration in eGFR to <20 ml/min/1.73m2 in the CREDENCE Trial', European Heart Journal, 46, http://dx.doi.org/10.1093/eurheartj/ehaf784.4190
, 2025, 'Risks of Hyperkalemia With Potassium-Enriched Salt Substitute Among Patients Using Concomitant Blockade of the Renin-Angiotensin-Aldosterone System in the Salt Substitute and Stroke Study', Circulation, 152, pp. 1311 - 1313, http://dx.doi.org/10.1161/CIRCULATIONAHA.125.075690
, 2025, 'Stakeholders' perspectives on barriers and enablers of chronic kidney disease care in Ethiopia: A qualitative study', Plos One, 20, http://dx.doi.org/10.1371/journal.pone.0336781
, 2025, 'Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset', BMJ Open, 15, pp. e096730 - e096730, http://dx.doi.org/10.1136/bmjopen-2024-096730
, 2025, 'Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management', Heart Lung and Circulation, 34, pp. 1060 - 1068, http://dx.doi.org/10.1016/j.hlc.2025.05.095
, 2025, 'Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset', Diabetes Obesity and Metabolism, 27, pp. 5599 - 5611, http://dx.doi.org/10.1111/dom.16608
, 2025, 'Quality of care for people with chronic kidney disease: a systematic review and meta-analysis', BMJ Open, 15, http://dx.doi.org/10.1136/bmjopen-2025-102044
, 2025, 'Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: Insights from the CREDENCE trial', Nephrology Dialysis Transplantation, 40, pp. 1727 - 1735, http://dx.doi.org/10.1093/ndt/gfaf044
, 2025, 'The epidemiology of haemodialysis catheter infections in Australia, 2016–20: a prospective cohort study', Medical Journal of Australia, 223, pp. 248 - 256, http://dx.doi.org/10.5694/mja2.70014
, 2025, 'Glomerular disease registry and biobank: design and baseline results', Internal Medicine Journal, 55, pp. 1301 - 1307, http://dx.doi.org/10.1111/imj.70056
, 2025, 'Prophylactic Antibiotics Before Insertion of Tunneled Hemodialysis Catheters: A Nationwide Cohort Study', Kidney Medicine, 7, http://dx.doi.org/10.1016/j.xkme.2025.101042
, 2025, 'Changes in Dialysis Practice Patterns in Australia and New Zealand During the COVID-19 Pandemic Period', Nephrology, 30, http://dx.doi.org/10.1111/nep.70077
, 2025, 'Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial', Diabetes Obesity and Metabolism, 27, pp. 3531 - 3535, http://dx.doi.org/10.1111/dom.16363
, 2025, 'Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial', Journal of the American Society of Nephrology, 36, pp. 901 - 910, http://dx.doi.org/10.1681/ASN.0000000000000495
, 2025, 'Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset', Lancet Regional Health Western Pacific, 57, http://dx.doi.org/10.1016/j.lanwpc.2025.101541
, 2025, 'Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial', Diabetes Obesity and Metabolism, 27, pp. 1972 - 1979, http://dx.doi.org/10.1111/dom.16190
, 2025, 'Risk factors associated with 30-day mortality following COVID-19 infection in patients receiving kidney replacement therapy in Australia and New Zealand', Internal Medicine Journal, 55, pp. 622 - 629, http://dx.doi.org/10.1111/imj.16628
, 2025, 'Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD', Kidney International Reports, 10, pp. 1037 - 1049, http://dx.doi.org/10.1016/j.ekir.2025.01.029
, 2025, 'Effects of Semaglutide on CKD in Patients With Type 2 Diabetes', Kidney International Reports, 10, pp. 287 - 290, http://dx.doi.org/10.1016/j.ekir.2024.11.1365
, 2025, 'Baseline Characteristics of ASSIST: Phase 2 Crossover Trial of Atrasentan in Adults with IgAN on SGLT2 Inhibitors', Journal of the American Society of Nephrology, 36, http://dx.doi.org/10.1681/asn.20251m9dyn78
, 2025, 'Glomerular Disease Registry and Biobank: Baseline and Follow-Up Results', Journal of the American Society of Nephrology, 36, pp. 10.1681/asn.2025a2e9nynn, http://dx.doi.org/10.1681/asn.2025a2e9nynn